4.2 Review

The Role of ARID1A in Endometrial Cancer and the Molecular Pathways Associated With Pathogenesis and Cancer Progression

Journal

IN VIVO
Volume 33, Issue 3, Pages 659-667

Publisher

INT INST ANTICANCER RESEARCH
DOI: 10.21873/invivo.11524

Keywords

ARID1A; endometrial cancer; molecular pathways; review

Ask authors/readers for more resources

AT-rich interaction domain 1A gene (ARID1A) encodes for a subunit of the switch/sucrose non fermentable (SWI/SNF) complex, a chromatin remodeling complex, and it has been implicated in the pathogenesis of various cancer types. In this review, we discuss how ARID1A is linked to endometrial cancer and what molecular pathways are affected by mutation or inhibition of ARID1A. We also discuss the potential use of ARID1A not only as a prognostic biomarker, but also as a target for therapeutic interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available